Formic Acid

Formic Acid

SCHEMBL4915522

O=CO.c1ccc(C2=NCCN2)c(Oc2cccc3ccccc23)c1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 13/20 0.60
PDCD1LG2 Q9BQ51 4/20 0.40
CD274 Q9NZQ7 4/20 0.40
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
CYP2D6 P10635 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
MAPK1 P28482 1/20 0.39
ADRA1A P35348 1/20 0.39
OPRM1 P35372 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL4813959 0.93 NISCH (0.51) NISCHPDCD1LG2CD274MAPTKDM4E
SCHEMBL4815704 0.92 NISCH (0.70) NISCHPDCD1LG2CD274MAPTLMNA
SCHEMBL6746697 0.85 NISCH (0.58) NISCHPDCD1LG2CD274MAPTKDM4E
Formic Acid SCHEMBL4904523 0.82 NISCH (0.49) NISCHKDM4EALDH1A1GAALMNA
SCHEMBL9575177 0.77 NISCH (1.00) NISCHMAPTKDM4EALDH1A1LMNA
Formic Acid SCHEMBL4820051 0.76 NISCH (0.41) NISCHPDCD1LG2CD274GAAADRA2A
Formic Acid SCHEMBL4813663 0.75 NISCH (0.41) NISCHGAA
SCHEMBL8186147 0.74 NISCH (0.87) NISCHMAPTKDM4EALDH1A1LMNA
SCHEMBL4823981 0.73 NISCH (0.56) NISCHKDM4EALDH1A1GAALMNA
Formic Acid SCHEMBL4912608 0.71 NISCH (0.51) NISCHMAPTGAALMNAHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269217-A1 Melanocortin-4 receptor binding compounds and methods of use thereof ORE PHARMACEUTICALS, INC. (US) 2008-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269217-A1 Melanocortin-4 receptor binding compounds and methods of use thereof MC4R, MC5R, MC3R NISCH 1934/4885PDCD1LG2 1529/4885CD274 1713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.